Coverage & Prior Authorization
Cleo helps you with the entire prior authorization workflow—from checking if PA is required to generating appeal letters with verifiable citations from the patient’s records.
How It Works
Section titled “How It Works”Cleo has access to the CMS Medicare Part D formulary database—over 1.3 million drug entries across hundreds of insurance plans. When you ask about a medication, Cleo checks:
- Prior Authorization — Is PA required? What percentage of plans require it?
- Step Therapy — Must the patient try other medications first?
- Quantity Limits — Are there dispensing restrictions?
- Tier Level — Generic, preferred brand, specialty, etc.
Asking About Medications
Section titled “Asking About Medications”In the Cleo side panel, you can ask questions like:
| Question | What You’ll Learn |
|---|---|
| ”Does Ozempic require prior auth?” | PA requirements across plans |
| ”What tier is metformin?” | Formulary tier distribution |
| ”Check coverage for Eliquis” | Full coverage summary |
| ”Is step therapy required for Humira?” | Step therapy status |
Understanding Results
Section titled “Understanding Results”When you ask about a medication, Cleo provides a summary like:
Formulary Coverage Summary (100 plans checked):
⚠️ Prior Authorization: REQUIRED in 85% of plans✅ Step Therapy: Not required📊 Quantity Limits: 4 pens per 28 days
Tier Distribution: Tier 3 (Preferred Brand): 15 plans Tier 5 (Specialty): 85 plansTier Levels Explained
Section titled “Tier Levels Explained”| Tier | Description | Typical Cost |
|---|---|---|
| Tier 1 | Preferred Generic | Lowest copay |
| Tier 2 | Generic | Low copay |
| Tier 3 | Preferred Brand | Moderate copay |
| Tier 4 | Non-Preferred | Higher copay |
| Tier 5 | Specialty | Highest cost, often % coinsurance |
Common Use Cases
Section titled “Common Use Cases”Before prescribing a new medication, ask Cleo:
“Does [medication] require prior auth?”
This helps you anticipate insurance hurdles and discuss alternatives with the patient if needed.
When a patient asks why their medication costs so much:
“What tier is [medication]?”
You can explain formulary placement and suggest lower-tier alternatives.
When you know PA will be required:
“What are the PA requirements for [medication]?”
Understand what documentation you’ll need to submit.
Generating PA Appeal Letters
Section titled “Generating PA Appeal Letters”When you need to submit a prior authorization, Cleo can search the patient’s records and generate a complete appeal letter with evidence.
What Cleo Searches
Section titled “What Cleo Searches”When you ask Cleo to generate a PA letter, it automatically searches:
- Medication history — Failed prior therapies, intolerance, adverse events
- Uploaded documents — Faxed records, referral letters, specialist notes
- Lab results — Supporting clinical evidence (A1c, eGFR, etc.)
- Conditions — Relevant diagnoses with ICD-10 codes
How to Generate a Letter
Section titled “How to Generate a Letter”-
Navigate to the patient’s chart in your EHR
-
Ask Cleo to generate a PA letter:
- “Generate a PA letter for Wegovy”
- “Write prior auth appeal for Ozempic for weight management”
- “Create PA letter for Humira”
-
Review the results — Cleo shows:
- Evidence found (failed therapies, contraindications)
- Supporting lab values
- Missing evidence warnings
-
Open in Hub — Click the attachment card to open the full PA Letter Editor
The PA Letter Editor
Section titled “The PA Letter Editor”After Cleo generates a letter, click “Open in Hub” to access the full editing experience:
| Tab | What You Can Do |
|---|---|
| Evidence Review | Toggle evidence to include/exclude, verify citations |
| Edit Letter | Modify the summary, conclusion, and sections |
| Export | Copy to clipboard or export as PDF |
Example Output
Section titled “Example Output”When you ask for a PA letter, Cleo generates something like:
WEGOVY
PA Required: YES (85% of plans)Step Therapy: Required
EVIDENCE FOUND (4): [!] Metformin (intolerance) "Discontinued due to severe GI distress..." Source: Epic - Primary Care, 2022-04-20
[X] Phentermine (contraindication) "Stopped due to hypertension with BP >160/95..." Source: Weight Management Clinic, 2023-05-15
--- DRAFT LETTER GENERATED ---Citations: 4
[Open in Hub to review and edit →]Data Source
Section titled “Data Source”Coverage information comes from the CMS Medicare Part D formulary files, updated quarterly. This covers:
- All Medicare Part D plans
- RXCUI and NDC drug identifiers
- Prior authorization flags
- Step therapy requirements
- Quantity limit details
- Tier level assignments
Limitations
Section titled “Limitations”- Medicare Part D only — Commercial and Medicaid plans not yet included
- Formulary data — Shows if PA is required, not the specific approval criteria
- Quarterly updates — Data refreshed each quarter when CMS releases new files
- Evidence quality — Letter quality depends on available patient records
For specific PA approval criteria (diagnosis requirements, prior medications tried, etc.), you may still need to check the payer’s clinical policy bulletins.